-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA Approves Talazoparib With Enzalutamide For Metastatic Androgen Pathway Modulation-Naive Or -Sensitive Prostate Cancer With Hrr Gene Mutations

Benzinga·10/26/2026 16:46:31
Listen to the news

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-talazoparib-enzalutamide-metastatic-androgen-pathway-modulation-naive-or-sensitive